Probenecid and Eugenol Mitigate Testosterone Induced Benign Prostatic Hyperplasia by Targeting Uric Acid‐Induced Inflammation and Pro‐Survival Pathways

Ähnliche Einträge

• The Mediterranean Diet and Benign Prostatic Hyperplasia: A Pathway to Improved Urinary Health
  von: İsa Dağlı, et al.
  Veröffentlicht: (2025)
• Association of Escherichia coli Infection and fimh Virulence With Benign Prostatic Hyperplasia in Ghanaian Patients
  von: Yvonne Anang, et al.
  Veröffentlicht: (2025)
• Prostatic Surgery With Preservation of the Supramonticular Tissue Versus Standard Surgery for Benign Prostatic Hyperplasia: A Systematic Review
  von: Giuston Mendoza‐Chuctaya, et al.
  Veröffentlicht: (2025)
• Safety and Efficacy of Bipolar Transurethral Vaporization of the Prostate and Bipolar Transurethral Resection of the Prostate in the Management of Large Volume Benign Prostatic Hyperplasia: A Prospective Randomized Study
  von: Amr M. Lotfy, et al.
  Veröffentlicht: (2026)
• c‐Kit‐Mediated PI3K/AKT and Wnt/β‐Catenin Signaling Drives Resistance to 5α‐Reductase Inhibitors in Benign Prostatic Hyperplasia
  von: Jun Zhu, et al.
  Veröffentlicht: (2025)